Morsa Images/DigitalVision via Getty Images
A Quick Take On MiNK Therapeutics
MiNK Therapeutics (INKT) intends to raise $52 million from the sale of its common stock in an IPO, according to an amended registration statement.
The company is developing…

Click here to view the original article.